HMGCR and neuroblastoma: Clinically, HMGCR overexpression is frequently observed in pediatric cancers such as NB, rhabdomyosarcoma, and osteosarcoma, where it promotes proliferation, invasion, and survival while reducing therapy efficacy (127–130).